Juvenile Primary Osteoporosis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Juvenile Primary Osteoporosis

MalaCards integrated aliases for Juvenile Primary Osteoporosis:

Name: Juvenile Primary Osteoporosis ⁴² ⁷¹

Childhood-Onset Primary Osteoporosis ⁴²

Idiopathic Juvenile Osteoporosis ⁴²

Juvenile Osteoporosis ⁷¹

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases
Anatomical: Bone diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C0264080 C3711559

Sources

Summaries for Juvenile Primary Osteoporosis

MedlinePlus Genetics: ⁴² Juvenile primary osteoporosis is a skeletal disorder characterized by thinning of the bones (osteoporosis) that begins in childhood. Osteoporosis is caused by a shortage of calcium and other minerals in bones (decreased bone mineral density), which makes the bones brittle and prone to fracture. Affected individuals often have multiple fractures in the long bones of the arms and legs, especially in the regions where new bone forms (metaphyses). They also have fractures in the bones that form the spine (vertebrae), which can cause collapse of the affected vertebrae (compressed vertebrae). Multiple fractures can cause bone pain and lead to movement problems.

MalaCards based summary: Juvenile Primary Osteoporosis, also known as childhood-onset primary osteoporosis, is related to osteoporosis, juvenile and osteoporosis. The drugs Alendronic acid and Calcium carbonate have been mentioned in the context of this disorder. Affiliated tissues include bone and skin.

Sources

Related Diseases for Juvenile Primary Osteoporosis

Diseases in the Osteoporosis family:

Osteoporosis, Juvenile	Juvenile Primary Osteoporosis
Lrp5-Related Primary Osteoporosis

Diseases related to Juvenile Primary Osteoporosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)

#	Related Disease	Score
1	osteoporosis, juvenile	11.9
2	osteoporosis	10.8
3	bone mineral density quantitative trait locus 8	10.8
4	bone mineral density quantitative trait locus 15	10.8
5	bone disease	10.4
6	brittle bone disorder	10.2
7	osteogenesis imperfecta, type i	10.1
8	osteogenesis imperfecta, type vi	10.1
9	hyperparathyroidism	10.1
10	down syndrome	9.9
11	osteogenesis imperfecta, type iii	9.9
12	bone mineral density quantitative trait locus 16	9.9
13	scoliosis	9.9
14	conn's syndrome	9.9
15	secondary hyperparathyroidism	9.9
16	ehlers-danlos syndrome	9.9
17	47 xxx syndrome	9.9
18	back pain	9.9

Graphical network of the top 20 diseases related to Juvenile Primary Osteoporosis:

Sources

Symptoms & Phenotypes for Juvenile Primary Osteoporosis

Sources

Drugs & Therapeutics for Juvenile Primary Osteoporosis

Drugs for Juvenile Primary Osteoporosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Alendronic acid

Approved

Phase 2

121268-17-5, 66376-36-1

2088

2

Calcium carbonate

Approved, Investigational

Phase 2

471-34-1

3

Cholecalciferol

Approved, Nutraceutical, Vet_approved

Phase 2

67-97-0, 1406-16-2

5280795 10883523

Synonyms:

(+)-Vitamin D3

(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL

(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL

(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL

(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol

(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL

(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol

3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL

7-DEHYDROCHOLESTEROL

9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL

9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL

9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL

9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL

ACCRETE D3

ACIFEROL D3

ACTIVATED

Activated 7-dehydrocholesterol

ADCAL-D3

ARACHITOL

AVITICOL

BIOLIFE VITAMIN D3

BIO-VITAMIN D3

CACIT D3

CALCEOS

CALCICHEW D3

CALCICHEW D3 FTE

CALCICHEW D3 ONCE DAILY

CALCI-D

Calciferol

Calciol

CALDRINK D3

CALFOVIT D3

CC

Cholecalciferol

CHOLECALCIFEROL D3

Cholecalciferols

Cholecalciferolum

COLECAL D3

Colecalciferol

Colecalciferolum

COLEKAL-D3

COLEVIT D3

CUBICOLE D3

D3 LEMON MELTS

D3-50

D3-VIGANTOL

DEKRISTOL

DELSTEROL

Delta-D

DEPARAL

DESUNIN

DEVARON

Dihydrocholesterol

DLUX 400

D-MAX

D-TRACETTEN

D-VIT3

EBIVIT

E-D3

EVACAL D3

FERACOL

FULTIUM DAILY D3

FULTIUM-D3

GRANUVIT D3

HUX D3

INVITA D3

ISO D3

KORA LIQUID

MICRO-DEE

NATECAL D3

NATURE'S REMEDY VITAMIN D3

NEO-D

NPHD3

NSC-375571

Oleovitamin D3

OSTEOCAPS D3

PLENACHOL

PRO D3

PRO D3 FOLIC

PRO D3 FORTE

PROVITINA

QUINTOX

RICKETON

ROYALVIT D3

STEXEROL-D3

STIVIT-D3

SUNVIT-D3 1,000

SUNVIT-D3 10,000

SUNVIT-D3 2,000

SUNVIT-D3 20,000

SUNVIT-D3 3,000

SUNVIT-D3 400

SUNVIT-D3 5,000

SUNVIT-D3 50,000

SUNVIT-D3 800

SYNERVIT-D3

THEICAL D-3

THORENS

TRIVITAN

VIDDE-3-HYDROSOL

VI-DE3

VIDEKHOL

VIGANTOL

VIGANTOLETTEN

VIGANTOLETTEN 500

VIGORSAN

VIT D3 STREULI

VITA-D3

VITAMIN D

Vitamin D 3

VITAMIN D ASSAY SYSTEM SUITABILITY

Vitamin D NOS

Vitamin D, unspecified form

Vitamin D3

Vitamin D-3

VITINC DAN-DEE-3

ZYMAD

δ-D

4

Ergocalciferol

Approved, Nutraceutical

Phase 2

50-14-6

5280793

Synonyms:

(+)-Vitamin D2

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL

(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL

(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL

(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

(3Β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol

(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol

(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol

22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol

4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol

9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol

Activated ergosterol

beta-Ol

Buco-D

Calciferol

CALCIFEROL IN ARACH OIL

Calciferols

Calciferon 2

CALTRATE

Condacaps

Condocaps

Condol

Crtron

Crystallina

D2, Vitamin

Daral

D-Arthin

Davitamon D

Davitin

Decaps

Dee-osterol

Dee-ron

Dee-ronal

Dee-roual

delta-Arthin

Deltalin

delta-Tracetten

De-rat concentrate

Deratol

Detalup

D-FORTE

Diactol

Divit urto

Doral

Drisdol

D-Tracetten

ECIFEROL D2

Ercalciol

Ergocalciferol

ERGOCALCIFÉROL

Ergocalciferol oil

Ergocalciferols

Ergocalciferolum

ERGO-D2

ERGORAL D2

Ergorone

Ergosterol activated

Ergosterol irradiated

Ertron

Fortodyl

Geltabs

Hi-deratol

Infron

Irradiated ergosta-5,7,22-trien-3beta-ol

LANES

Metadee

Mina D2

Mulsiferol

Mykostin

Novovitamin-D

NSC-62792

Oleovitamin D

OLEOVITAMIN D, SYNTHETIC

Oleovitamin D2

Osteil

Ostelin

OSTO-D2

Radiostol

Radstein

Radsterin

Rodine C

Shock-ferol

Shock-ferol sterogyl

Sterogyl

STEROGYL 15H

STEROGYL-15

Synthetic vitamin D

Uvesterol D

Uvesterol-D

Vio D

Vio-D

Viostdrol

Viosterol

Viosterol in oil

VITAMIN D

Vitamin D 2

Vitamin D2

Vitamina D2

Vitavel-D

5

glucocorticoids

Phase 2

6

Diphosphonates

Phase 2

7

Vitamins

Phase 2

8

Vitamin D2

Phase 2

3249

9

Calciferol

Phase 2

10

Ergocalciferols

Phase 2

11

Calcium, Dietary

Phase 2

12

Calcium

Nutraceutical

Phase 2

7440-70-2

271

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Alendronate Versus Placebo for Idiopathic Juvenile Osteoporosis	Completed	NCT00001720	Phase 2	Alendronate
2	A Randomized, Double-Blind, Placebo-Controlled, Prospective, Cross-Over Phase II Clinical Trial to Determine the Safety and Efficacy of Alendronate (Fosamax) in Juvenile Osteoporosis (IND#60,017)	Completed	NCT00259857	Phase 2	Alendronate
3	Phase II Study of Alendronate Sodium in Juvenile Osteoporosis (IND# 60,017)-Post Study Evaluation of Participants From Phase IIa and Phase IIb Clinical Study.	Completed	NCT00920075		Alendronate (Fosamax)

Search NIH Clinical Center for Juvenile Primary Osteoporosis

Sources

Genetic Tests for Juvenile Primary Osteoporosis

Sources

Anatomical Context for Juvenile Primary Osteoporosis

Organs/tissues related to Juvenile Primary Osteoporosis:

MalaCards : Bone, Skin

Sources

Publications for Juvenile Primary Osteoporosis

Articles related to Juvenile Primary Osteoporosis:

(show top 50) (show all 97)

#	Title	Authors	PMID	Year
1	Idiopathic juvenile osteoporosis in a child: a four-year follow-up with review of literature. ⁶²	Dabas A...Khadgawat R	34331423	2021
2	Progressive idiopathic juvenile osteoporosis in pregnancy: A case report of two successive pregnancies in the same woman. ⁶²	Kishimoto K...Katabuchi H	34040998	2021
3	Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents. ⁶²	Yoon JH...Choi JH	34218632	2021
4	Do Bisphosphonates Alleviate Pain in Children? A Systematic Review. ⁶²	Celin MR...Harris GF	32960409	2020
5	Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties. ⁶²	Balasubramanian M...Bishop NJ	29736964	2018
6	PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization. ⁶²	Kampe AJ...Makitie O	28777485	2017
7	PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. ⁶²	Kampe AJ...Makitie O	28748388	2017
8	Primary osteoporosis in children. ⁶²	Tan LO...Vasanwala RF	28866630	2017
9	A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl. ⁶²	Boyce AM...Gafni RI	27379824	2017
10	Abnormal Proteoglycan Synthesis Due to Gene Defects Causes Skeletal Diseases with Overlapping Phenotypes. ⁶²	Taylan F...Makitie O	27871115	2016
11	[Osteoporosis - epidemiology and pathogenesis]. ⁶²	Sotornik I	28124937	2016
12	Evidence of altered matrix composition in iliac crest biopsies from patients with idiopathic juvenile osteoporosis. ⁶²	Garcia I...Boskey A	26539896	2016
13	Idiopathic Juvenile Osteoporosis: A Case Report. ⁶²	Altan H...Sen Y	26436063	2015
14	Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes. ⁶²	Franceschi R...Mughal MZ	25783012	2015
15	Radiographic and MR Imaging Findings of the Spine after Bisphosphonate Treatment, in a Child with Idiopathic Juvenile Osteoporosis. ⁶²	Papakonstantinou O...Alexopoulou E	25688321	2015
16	Idiopathic juvenile osteoporosis: A case report and review of the literature. ⁶²	Imerci A...Kocak M	25768278	2015
17	New Genetic Forms of Childhood-Onset Primary Osteoporosis. ⁶²	Kampe AJ...Makitie O	26517534	2015
18	The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review. ⁶²	Ngan KK...Goodger N	24386765	2013
19	[Idiopathic juvenile osteoporosis]. ⁶²	Guagnelli MA...Carrascosa A	23490432	2013
20	Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients. ⁶²	Baroncelli GI...Giuca MR	23549954	2013
21	Causes, mechanisms and management of paediatric osteoporosis. ⁶²	Makitie O	23591487	2013
22	Juvenile osteoporosis in a 5-year-old girl. ⁶²	Sanghai SR...Shah I	24082756	2013
23	Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. ⁶²	Bacchetta J...Salusky IB	23418950	2013
24	Rare variations in WNT3A and DKK1 may predispose carriers to primary osteoporosis. ⁶²	Korvala J...Mannikko M	22789636	2012
25	Calvarial doughnut lesions and osteoporosis: a new three-generation family and review. ⁶²	Jaakkola E...Makitie O	19839042	2009
26	Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia. ⁶²	Atas A...Varma M	19636264	2009
27	Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship. ⁶²	Pludowski P...Lorenc RS	16951909	2006
28	Bisphosphonate treatment of pediatric bone disease. ⁶²	Speiser PW...LWPES Pharmacy and Therapeutic Committee	16361982	2005
29	How to manage osteoporosis in children. ⁶²	Bianchi ML	16301193	2005
30	Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis. ⁶²	Melchior R...Schumacher R	15517381	2005
31	Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder? ⁶²	Munns CF...Glorieux FH	15542026	2004
32	Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. ⁶²	Baroncelli GI...Saggese G	12700367	2003
33	The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. ⁶²	Rauch F...Glorieux FH	12110417	2002
34	Idiopathic juvenile osteoporosis. ⁶²	Lorenc RS	11973603	2002
35	Use of bisphosphonates in children and adolescents. ⁶²	Allgrove J	12199351	2002
36	Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature. ⁶²	Kauffman RP...Jennings JC	11496161	2001
37	Clinical evaluation of patients with idiopathic juvenile osteoporosis. ⁶²	Chlebna-Sokol D...Sikora A	11497372	2001
38	Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathic juvenile osteoporosis. ⁶²	Wright NM	11086654	2000
39	Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. ⁶²	Rauch F...Glorieux FH	10804027	2000
40	[Clinical observation of osteoporosis in adolescents]. ⁶²	Chlebna-Sokol D...Sikora A	10907348	2000
41	Idiopathic juvenile osteoporosis. ⁶²	Krassas GE	10818429	2000
42	[Osteoporosis in children]. ⁶²	Lorenc RS...Olszaniecka M	10907357	2000
43	[Idiopathic juvenile osteoporosis: a new observation]. ⁶²	Joseph-Gaudry J...Bourrillon A	10472398	1999
44	Difficulty walking. A presentation of idiopathic juvenile osteoporosis. ⁶²	Villaverde V...Garcia-Consuegra J	9458225	1998
45	How do we manage specific types of osteoporosis? ⁶²	Sambrook PN...Naganathan V	9367039	1997
46	Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers--Danlos syndrome. ⁶²	Proszynska K...Lorenc RS	8816205	1996
47	Idiopathic juvenile osteoporosis. An unusual cause of back pain in an adolescent. ⁶²	Dimar JR...Johnson JR	8581446	1995
48	Type I collagen biosynthesis by skin fibroblasts from patients with idiopathic juvenile osteoporosis. ⁶²	Pocock AE...Smith R	7671570	1995
49	Idiopathic juvenile osteoporosis: five-year case follow-up. ⁶²	Hou JW...Wang TR	7613264	1995
50	Estrogen and diclofenac sodium therapy in a prepubertal female with idiopathic juvenile osteoporosis. ⁶²	Wright NM...Key LL	7584708	1995

Sources

Genes for Juvenile Primary Osteoporosis

Sources

Variations for Juvenile Primary Osteoporosis

Sources

Expression for Juvenile Primary Osteoporosis

Search GEO for disease gene expression data for Juvenile Primary Osteoporosis.

Sources

Pathways for Juvenile Primary Osteoporosis

Sources

GO Terms for Juvenile Primary Osteoporosis

Sources

Sources for Juvenile Primary Osteoporosis

¹ BitterDB

² CDC

³ Cell Signaling Technology

⁴ ClinicalTrials

⁵ ClinVar

⁶ CNVD

⁷ Cochrane Library

⁸ Cosmic

⁹ dbSNP

¹⁰ DGIdb

¹¹ Disease Ontology

¹² diseasecard

¹³ DiseaseEnhancer

¹⁴ DISEASES

¹⁵ DrugBank

¹⁶ EFO

¹⁷ ExPASy

¹⁸ FMA

¹⁹ GARD

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ GenomeRNAi

²⁶ GEO DataSets

²⁷ GO

²⁸ GTR

²⁹ HMDB

³⁰ HPO

³¹ ICD10

³² ICD10 via Orphanet

³³ ICD11

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ LifeMap

³⁷ LncRNADisease

³⁸ LOVD

³⁹ MalaCards

⁴⁰ MedGen

⁴¹ MedlinePlus

⁴² MedlinePlus Genetics

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NINDS

⁵³ Novoseek

⁵⁴ Novus Biologicals

⁵⁵ ODiseA

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 08-Dec-2022)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubChem

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ WikiPathways

⁷⁵ Wikipedia

MCID: JVN025 MIFTS: 21	Juvenile Primary Osteoporosis Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases	Data Licensing For inquiries, contact: [email protected]
Tissues Related diseases Publications Drugs Expand all tables